PRRT2 Gene Changes Linked To Infant Epilepsy In India

What was studied

Researchers looked at 15 children with self-limiting familial infantile epilepsy (SeLFIE), a type of epilepsy that starts in infancy and can run in families. They recorded the children’s clinical features and tested the PRRT2 gene using Sanger sequencing.

The goal was to examine which PRRT2 gene changes were present in these children and how those findings related to SeLFIE. The study also described which seizure medicines were used and whether seizures came under control.

What they found

Most of the children, 12 out of 15, had the common PRRT2 change c.649dupC. The other 3 children had different PRRT2 variants: c.649delC, c.696C>G, and c.649C>T. The authors state that this broadens the known spectrum of PRRT2 variants associated with SeLFIE.

All patients were reported to become seizure-free after treatment was changed to sodium channel blocker medicines such as oxcarbazepine, phenytoin, or carbamazepine. The authors describe oxcarbazepine as highly effective for seizure control.

Limits of the evidence

This was a small study with only 15 patients, so the results may not apply to every child with SeLFIE. It was not a comparison trial, so it cannot show that one medicine works better than another or that the genetic findings explain the treatment response.

The abstract gives limited detail about family history, follow-up length, side effects, and the clinical features of each patient. Because of that, there is still uncertainty about how broadly these findings should be applied.

For families and caregivers

For families, this study suggests that PRRT2 testing may help support the diagnosis in many children with SeLFIE and may help guide management. It also reports that sodium channel blocker medicines were associated with seizure freedom in this small group.

Still, families should know this does not mean every child with SeLFIE or every PRRT2 variant will respond the same way. Treatment choices should still be based on a child’s full clinical picture and discussion with the neurology team.

What to watch next

Larger studies with longer follow-up and direct comparisons of seizure medicines in children with different PRRT2 variants would help clarify these findings.

Terms in this summary

self-limiting familial infantile epilepsy (SeLFIE)

An epilepsy syndrome that begins in infancy, often runs in families, and is characterized by recurrent focal motor seizures.

PRRT2 gene

A gene associated with SeLFIE and other neurologic conditions.

autosomal dominant

A pattern of inheritance where a change in one copy of a gene can be enough to be passed through families.

focal motor seizures

Seizures that start in one part of the brain and cause movement symptoms, such as jerking or stiffening.

frameshift variant

A DNA change that shifts how the gene is read, often leading to a shortened or altered protein.

missense variant

A DNA change that swaps one building block of a protein for another.

nonsense variant

A DNA change that creates an early stop signal, making the protein shorter than usual.

Sanger sequencing

A lab method used to read the DNA code of a gene.